Skip to main content
. 2020 Feb 21;16(8):1363–1375. doi: 10.7150/ijbs.41395

Table 2.

Slope and y intercepts values of three calibration curve of niraparib and olaparib spotted in the same working day. SD and CV% is presented for each m and q and comparing different curves.

Niraparib Olaparib
m±SD (CV%)
[Udrug/(pmol/mm2)]*
q±SD (CV%)
[Udrug)]*
m±SD (CV%)
[Udrug/(pmol/mm2)]*
q±SD (CV%)
[Udrug)]*
Rep 1 0.296±0.035 (11.8) 0.101±0.016 (15.9) 0.093±0.014 (14.7) 0.0527±0.0014 (2.7)
Rep 2 0.312±0.022 (7.1) 0.104±0.009 (8.5) 0.121±0.012 (9.7) 0.0529±0.0012 (2.3)
Rep 3 0.268±0.018 (6.8) 0.104±0.008 (8.1) 0.147±0.014 (9.4) 0.0528±0.0012 (2.2)
MEAN 0.292 0.103 0.120 0.0528
SD 0.022 0.002 0.027 0.0001
CV% 7.6 1.7 22.3 0.2

* Udrug : unit of the normalised drug signal (dimensionless)